DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20164318

Sero-prevalence and risk factors associated with toxoplasma gondii infection among pregnant women in Alexandria, Egypt

Hassan K. Bassiouny, Nadia K. Soliman, Sally El Tawab, Safaa Mohamed Eassa, Amira Eissa

Abstract


Background: Toxoplasma gondii infection during pregnancy can result in fetal death, neonatal death or various congenital defects. This study aimed to estimate the seroprevalence of toxoplasma gondii infection using two different diagnostic tests, Enzyme-Linked Immunosorbent Assay (ELISA) versus Immunochromatographic assay (ICA) and to study the potential risk factors for acquiring infection in pregnant women attending antenatal care clinics in Alexandria, Egypt.

Methods: A cross sectional study, conducted between May 2015 and June 2016. The study was done in antenatal care centers of most districts of Alexandria Governorate, Egypt. 382 pregnant women, of a gestational age between 8-40 weeks were included in the study and were given pretested structured questionnaire to assess risk factors, which included: demographic, socio-economic data, kitchen hygiene and behavioral variables. Blood samples were taken and sera were divided into two parts; the first part was examined for anti-T.gondii IgG and IgM antibodies using rapid diagnostic test RDT kit, the other part tested by ELISA.

Results: The overall seroprevalence of T.gondii infection was (11.3%) detected by RDT, significantly increased to (57.9%) by ELISA test (X2= 5.3; p=0.001). RDT had the sensitivity of (15.8%), the specificity of (95%), PPV of (81.4%), NPV of (45.1%), with overall diagnostic efficiency of (49.2%). The association between T.gondii infection and the age of the pregnant women was found to be statistically significant (OR=2.84, 95%CI=1.251-6.455).

Conclusions: The present study has documented a bad diagnostic performance of RDT in detection T.gondii in serum samples of infected pregnant women as compared to ELISA technique. Age is the only risk factor to be associated statistically with toxoplasma gondii infection.


Keywords


Antenatal care, Sero-prevalence, Toxoplasma gondii

Full Text:

PDF

References


Dubey JP. The history of Toxoplasma gondii – the first 100 years. J Eukaryot Microbiol. 2008;55(6):467-75.

Dubey JP. The discovery of the life cycle of Toxoplasma gondii. Int J Parasitol. 2009;39(8):877-82.

Periera KS, Franco RM, Leal DA. Transmission of toxoplasmosis (Toxoplasma gondii) by foods. Adv Food Nutr Res. 2010;60:1-19.

Flegr J, Priplatova L, Hampl R, Bicikovia M, Ripova D, Mohr P. Difference of neuro-and immunomodulatory steroids and Selected hormone and lipid concentration between Toxoplasma-free and Toxoplasma-infected but not CMV-free and CMV-infected schizophrenia patients. Neuro Endocrinal Lett. 2014;35(1):20-7.

Durlach RA, Kaufer F, Carral L, Hirt J. Toxoplasmic lymphadenitis-clinical and serologic profile. Clin Microbiol Infect. 2003;9(7):625-31

Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):1257-78.

Montoya JG, Rosso F: Diagnosis and management of Toxoplasmosis. Clin Perinatal. 2005;32:705-26.

Kravetz J. Congenital toxoplasmosis. Clinical Evidence. 2013;1:33-6.

Gomez-Marin, J. E. Congenital toxoplasmosis in South American children. Scientia Medica (Porto Alegre). 2010;20(6):103-7.

Naing L, Winn T, Rusil BN. Practical issues in calculating sample size for prevalence studies. Arch Orofac Sci. 2006;1:9-14.

El-Gozamy BR, Mohamed SA, Mansour HA. Toxoplasmosis among pregnant women in Qualyobia governorate, Egypt. J Egypt Soc Parasitol. 2009;39(2):389-401.

Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74.

Eusebi P. Diagnostic accuracy measures. Cerebrovasc Dis. 2013;36:267-72.

Victoria CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol, 1997;26:224-7.

Jones J, Lopez A, Wilson M. Congenital toxoplasmosis. Am Fam Pysician. 2003;67(10):2131- 8.

El-Moamly AA. Immuno-chromatographic Techniques: Benefits for the Diagnosis of Parasitic Infections. Austin Chromatogr. 2014;1(4):1-8.

Sudan V, Jaiswal AK, Shanker D. Recent trends in the diagnosis of toxoplasmosis. Clin Rev Opinions. 2013;5(2):11-7.

Abd elkareem BA, Eltayeb MM. Seropositivity of toxoplasmosis in Sudanese males blood donors in militarie hospital Omdurman, Sudan. IJB. 2015;6(3):147-9.

Huang X, Xuan X, Hirata H, Yokoyama N, Xu L, Suzuki N, et al. Rapid immunochromatographic test using recombinant SAG 2 for detection of antibodies againist Toxoplasma gondii in cats. J Clin Microbiol. 2004;42(1):351-3.

Hassan JS, Ghazi HF, Ahmed AAH. Evaluation of rapid chromatographic immunoassay with latex agglutination test and (ELISA) for diagnosis of human toxoplasmosis. Fac Med Paghdad. 2010;52(4):468-70.

Terkawi MA, Kameyama K, Rasul NH, Xuan X, Nishikawa Y. Development of an Immunochromatographic Assay Based on Dense Granule Protein 7 for Serological Detection of Toxoplasma gondii Infection. Clin Vaccine Immunol. 2013;20(4):596-601.

Nijem KI, Al-Amleh S. Seroprevalence and associated risk factors of toxoplasmosis in pregnant women in Hebron district, Palestine. EMHJ. 2009;15(5):1278- 84.

Cvetkovik D, Bobic B, Jankovska G, Klun I, Panovski N, Djurkovic-Djakovic O. Risk factors of Toxoplasma infection in pregnant women in FYR of Macedonia. Parasite. 2010;17:183- 6.

Sakikawa M, Noda S, Hanaoka M, Nakayama H, Hojo S, Kakinoki S, et al. Anti-Toxoplasma antibodies prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vaccin Imunol. 2012;19(3):365-7.

Flatt A, Shetty N. Seroprevalence and risk factors for toxoplasmosis among antenatal women in London: a re-examination of risk in an ethnically diverse population. Eur J Public Health. 2013;23(4):648-52.

Aqueely H, El-Gayar EK, Perveen Khan D, Najmi A, Alvi A, Bani I, et al. Seroproepidemiology of Toxoplasma gondii among pregnant women in Jazan Province, Saudi Arabia. J Trop Med. 2014.

Nassef NE, Abd El-Ghaffar MM, El-Nahas NS, Hassanain ME, Shams El-Din SA, Ammar AI. Seroprevalence and genotyping of Toxoplasma gondii in Menufia governorate. Menufia Med J. 2015;28(3):617-27.

Almushait MA, Bin Dajem SM, Elsherbiny NM, Eskandar MA, Al Azraqi TA, Makhlouf LM. Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in south western, Saudi Arabia. J Parasit Dis. 2014;38(1):4-10.

Sroka S, Bartelheimer N, Winter A, Heukelbach J, Ariza L, Ribeiro H. Prevalence and Risk Factors of Toxoplasmosis among Pregnant Women in Fortaleza, Northeastern Brazil. Am J Trop Med Hyg. 2010;83(3):528-33.

Al-Eryani SMA, Al-Mekhlafi AM, Al-Shibani LA, Mahdy MMK, Azazy AA. Toxoplasma gondii infection among pregnant women in Yemen: Factors associated with high seroprevalence. J Infect Dev Ctries. 2016;10(6):667-72.

Andiappan H, Nissapatorn V, Sawangjaroen N, Chemoh W, Lau YL, Kumar T, et al. Toxoplasma infection in pregnant women: a current status in Songklanagarind hospital, southern Thailand. Parasit Vectors. 2014;7:239.